Non-invasive refractive treatment using nanoparticles
AssigneeAMO Wavefront Sciences, LLC
InventorsThomas D. Raymond, Richard J. Copland
Life of this patent
Estimating the term…
Abstract
Embodiments of this invention generally relate to systems and methods for optical treatment and more particularly to non-invasive refractive treatment method based on sub wavelength particle implantation. In an embodiment, a method for optical treatment identifies an optical aberration of an eye, determines a dopant delivery device configuration in response to the optical aberration of the eye, wherein the determined dopant delivery device is configured to impose a desired correction to the eye to mitigate the identified optical aberration of the eye by applying a doping pattern to the eye so as to locally change a refractive index of the eye.
Claims25
A method for optical treatment, the method comprising:
- identifying an optical aberration of an eye, and
- determining a dopant delivery device configuration in response to the optical aberration of the eye, wherein the determined dopant delivery device is configured to impose a desired correction to the eye to mitigate the identified optical aberration of the eye by applying a doping pattern to a cornea of the eye so as to locally change a refractive index of the cornea without reshaping the cornea.
A method of providing non-invasive optical correction to an eye comprising:
- identifying the optical aberration of the eye;
- calculating a doping pattern configured to compensate for the optical aberration of the eye, wherein the doping pattern comprises a description of the location and concentration for dopant application to a cornea of the eye;
- configuring a dopant delivery system;
- delivering dopant to the cornea of the eye according to the calculated doping pattern without reshaping the cornea.
(canceled)
Dependencies are inferred from the claim text.